EV158 LOW-DOSE ZICONOTIDE AS FIRST-LINE INTRATHECAL MONOTHERAPY: A CASE SERIES WITH A 54- MONTH FOLLOW-UP

Neuromodulation Technology at the Neural Interface 2026

View at publisher
Authors: Georgios Matis, Veerle E. R. M. Visser-Vandewalle
DOI: 10.1016/j.neurom.2025.09.158
Cited by: 0

Fields of Study & Subjects

Intraperitoneal and Appendiceal Malignancies CNS Lymphoma Diagnosis and Treatment Glioma Diagnosis and Treatment

Publication details

Journal / source
Neuromodulation Technology at the Neural Interface
Volume
29
Issue
1
Pages
S115–S115
Publication date
1 January 2026
Language
EN